Northern Trust Corp Codexis, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Codexis, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 589,933 shares of CDXS stock, worth $3.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

589,933

Previous 588,759 0.2%

Holding current value

$3.02 Million

Previous $1.83 Million 0.49%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.62 - $3.71 $3,075 - $4,355	1,174 Added 0.2%	589,933 $1.82 Million
Q2 2024 Aug 14, 2024	SELL	$2.65 - $3.92 $7,732 - $11,438	-2,918 Reduced 0.49%	588,759 $1.83 Million
Q1 2024 May 14, 2024	SELL	$2.59 - $4.65 $55,941 - $100,435	-21,599 Reduced 3.52%	591,677 $2.06 Million
Q4 2023 Feb 13, 2024	BUY	$1.54 - $3.37 $72,430 - $158,501	47,033 Added 8.31%	613,276 $1.87 Million
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.75 $10,255 - $25,638	6,837 Added 1.22%	566,243 $1.07 Million
Q2 2023 Aug 11, 2023	SELL	$2.21 - $4.43 $93,938 - $188,301	-42,506 Reduced 7.06%	559,406 $1.57 Million
Q1 2023 May 15, 2023	BUY	$3.81 - $6.76 $95,448 - $169,351	25,052 Added 4.34%	601,912 $2.49 Million
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $150,326 - $241,369	-35,288 Reduced 5.76%	576,860 $2.69 Million
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $1,605 - $3,407	265 Added 0.04%	612,148 $3.71 Million
Q2 2022 Aug 12, 2022	SELL	$8.35 - $21.89 $138,668 - $363,527	-16,607 Reduced 2.64%	611,883 $6.4 Million
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $568,919 - $1.07 Million	-33,525 Reduced 5.06%	628,490 $13 Million
Q4 2021 Feb 08, 2022	SELL	$25.61 - $41.78 $342,175 - $558,222	-13,361 Reduced 1.98%	662,015 $20.7 Million
Q3 2021 Nov 15, 2021	BUY	$19.65 - $27.99 $68,460 - $97,517	3,484 Added 0.52%	675,376 $15.7 Million
Q2 2021 Aug 13, 2021	BUY	$17.48 - $25.46 $275,764 - $401,656	15,776 Added 2.4%	671,892 $15.2 Million
Q1 2021 May 12, 2021	SELL	$18.08 - $28.8 $129,109 - $205,660	-7,141 Reduced 1.08%	656,116 $15 Million
Q4 2020 Feb 11, 2021	SELL	$11.7 - $23.41 $162,910 - $325,960	-13,924 Reduced 2.06%	663,257 $14.5 Million
Q3 2020 Nov 16, 2020	SELL	$11.21 - $13.82 $407,618 - $502,522	-36,362 Reduced 5.1%	677,181 $7.95 Million
Q2 2020 Aug 14, 2020	SELL	$9.8 - $12.77 $1.5 Million - $1.95 Million	-152,753 Reduced 17.63%	713,543 $8.14 Million
Q1 2020 May 14, 2020	BUY	$8.78 - $18.6 $1.06 Million - $2.24 Million	120,679 Added 16.19%	866,296 $9.67 Million
Q4 2019 Feb 14, 2020	SELL	$13.12 - $17.06 $230,177 - $299,300	-17,544 Reduced 2.3%	745,617 $11.9 Million
Q3 2019 Nov 13, 2019	BUY	$12.75 - $19.01 $429,930 - $641,017	33,720 Added 4.62%	763,161 $10.5 Million
Q2 2019 Aug 13, 2019	BUY	$17.0 - $21.88 $1.52 Million - $1.95 Million	89,320 Added 13.95%	729,441 $13.4 Million
Q1 2019 May 13, 2019	BUY	$15.53 - $22.15 $225,868 - $322,149	14,544 Added 2.32%	640,121 $13.1 Million
Q4 2018 Feb 12, 2019	BUY	$14.06 - $22.57 $16,084 - $25,820	1,144 Added 0.18%	625,577 $10.4 Million
Q3 2018 Nov 14, 2018	BUY	$13.35 - $19.1 $583,501 - $834,822	43,708 Added 7.53%	624,433 $10.7 Million
Q2 2018 Sep 18, 2018	SELL	$10.35 - $16.45 $30,791 - $48,938	-2,975 Reduced 0.51%	580,725 $8.36 Million
Q2 2018 Aug 14, 2018	BUY	$10.35 - $16.45 $1.58 Million - $2.51 Million	152,808 Added 35.46%	583,700 $8.41 Million
Q1 2018 May 09, 2018	BUY	$8.0 - $12.8 $11,624 - $18,598	1,453 Added 0.34%	430,892 $4.74 Million
Q4 2017 Feb 14, 2018	SELL	$5.85 - $8.4 $144,851 - $207,992	-24,761 Reduced 5.45%	429,439 $3.59 Million
Q3 2017 Nov 13, 2017	BUY	$4.9 - $6.65 $2.23 Million - $3.02 Million	454,200	454,200 $3.02 Million

Others Institutions Holding CDXS

# of Institutions

125

Shares Held

59.9M

Call Options Held

25.9K

Put Options Held

20.1K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $335M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Codexis, Inc. Transaction History